Literature DB >> 15757824

Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B.

Ioannis Ketikoglou1, Stelios Karatapanis, Ioannis Elefsiniotis, Georgia Kafiri, Antonios Moulakakis.   

Abstract

A 32-year-old man with chronic hepatitis B who was treated with pegylated interferon alpha-2b once a week, developed widespread psoriasis 4 weeks after the beginning of the treatment. There was no history of psoriasis. The treatment was stopped and gradually the eruption vanished. Thereafter, the patient was treated with lamivudine successfully without dermatological or other sequelae.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757824

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  20 in total

Review 1.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

2.  Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.

Authors:  Guang Yang; Min Wan; Yongsheng Zhang; Luguo Sun; Ran Sun; Dali Hu; Xiaojing Zhou; Li Wang; Xiuli Wu; Liying Wang; Yongli Yu
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

3.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

4.  Hepatitis C virus infection and its rheumatologic implications.

Authors:  Zeynel A Sayiner; Uzma Haque; Mohammad U Malik; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-05

5.  Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis.

Authors:  Marie-José Bijlmakers; Seshu K Kanneganti; Jonathan N Barker; Richard C Trembath; Francesca Capon
Journal:  Hum Mol Genet       Date:  2011-05-13       Impact factor: 6.150

6.  Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.

Authors:  Ann L Truelove; Taras K Oleksyk; Sadeep Shrestha; Chloe L Thio; James J Goedert; Sharyne M Donfield; Gregory D Kirk; David L Thomas; Stephen J O'Brien; Michael W Smith
Journal:  Int J Immunogenet       Date:  2008-06       Impact factor: 1.466

Review 7.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

Review 8.  A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.

Authors:  Nisha Mistry; Jonathan Shapero; Richard I Crawford
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

9.  Learning the lessons of antitumour necrosis factor therapy-associated psoriasis.

Authors:  Matt Shale; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

Review 10.  Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature.

Authors:  Muhammed Sait Dag; Zeynel Abidin Oztürk; Nimet Yılmaz; Hakan Cam; Abdurrahman Kadayıfçı
Journal:  Wien Klin Wochenschr       Date:  2013-08-03       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.